Dr. Windebank is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1977 - 1982
Oxford University Medical SchoolClass of 1975
Certifications & Licensure
MN State Medical License 1979 - 2025- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
Clinical Trials
- Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2010 Jun 01
- A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis Start of enrollment: 2012 May 01
- Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS Start of enrollment: 2014 May 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAuthor Correction: Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial.Mohamad Bydon, Wenchun Qu, F M Moinuddin, Christine L Hunt, Kristin L Garlanger
Nature Communications. 2024-06-05 - 1 citationsDebamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes.Stacy R Lindborg, Namita A Goyal, Jonathan Katz, Matthew Burford, Jenny Li
Muscle & Nerve. 2024-06-01 - 10 citationsIntrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial.Mohamad Bydon, Wenchun Qu, F M Moinuddin, Christine L Hunt, Kristin L Garlanger
Nature Communications. 2024-04-01
Press Mentions
Regenerative Pipeline for Spinal Cord RepairJune 17th, 2021
What’s Next for the Research of the FutureJanuary 22nd, 2020- Meet Peter Grahn, Ph.D. — “I’ve Never Heard No”July 11th, 2019
- Join now to see all
Grant Support
- Mechanisms Of Neuronal Death And NeuroprotectionNational Institute Of Neurological Disorders And Stroke2004–2010
- Biodegradable Polymer Implants For Spinal Cord RepairNational Institute Of Biomedical Imaging And Bioengineering2004–2006
- Biodegradable Polymer Implants For Spinal Cord RepairNational Institute Of Biomedical Imaging And Bioengineering2003
- Mechanisms Of Neuronal Death And NeuroprotectionNational Institute Of Neurological Disorders And Stroke2000–2003
- Predoctoral Program In Neuroscience Of Human DiseaseNational Institute Of Neurological Disorders And Stroke1997–2003
- 3,4 Diaminopyridine Treatment Of Hereditary NeuropathyNational Center For Research Resources1993–1995
- In Vitro Studies Of Suramin NeurotoxicityNational Institute Of Neurological Disorders And Stroke1992–1994
- Cellular Mechanisms Of Experimental LEAD NeuropathyNational Institute Of Neurological Disorders And Stroke1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
